List Results  
  Refine Search  
  Results by Topic  
  Results on Map  
  Search Details  
Found 26 studies with search of:   "Genmab" [Exact]
Hide studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Recruiting Zalutumumab in Combination With Chemotherapy and Radiotherapy in Head and Neck Cancer
Conditions: Head and Neck Cancer;   Squamous Cell Cancer
Interventions: Drug: zalutumumab;   Drug: cisplatin;   Procedure: Radiotherapy
2 Completed Trial With HuMax-CD4 in Patients With Rheumatoid Arthritis Failing Treatment With Methotrexate and a TNF-Alpha Blocker
Condition: Rheumatoid Arthritis
Intervention: Drug: HuMax-CD4
3 Recruiting Zalutumumab in Non-Curable Patients With SCCHN
Conditions: Head and Neck Cancer;   Squamous Cell Cancer
Intervention: Drug: Zalutumumab
4 Completed HuMax-CD20 in Chronic Lymphocytic Leukemia
Condition: Chronic Lymphocytic Leukemia
Intervention: Drug: HuMax-CD20
5 Recruiting Long-Term Efficacy and Safety of Repeated Ofatumumab Treatment Courses in Rheumatoid Arthritis (RA) Patients Who Previously Received Ofatumumab or Placebo in Trial Hx-CD20-403
Condition: Arthritis, Rheumatoid
Intervention: Drug: Ofatumumab
6 Terminated Zalutumumab With or Without Irinotecan Chemotherapy in Cetuximab-Refractory Colorectal Cancer
Condition: Colorectal Cancer
Interventions: Drug: Zalutumumab with or without Irinotecan;   Drug: Zalutumumab with Irinotecan
7 Recruiting Investigating Clinical Efficacy of Ofatumumab in Adult RA Patients Who Had an Inadequate Response to TNF-α Antagonist Therapy
Conditions: Arthritis, Rheumatoid;   Rheumatoid Arthritis
Interventions: Drug: Ofatumumab;   Drug: Placebo
8 Completed HuMax-CD20 in Active Rheumatoid Arthritis
Condition: Acute Rheumatic Arthritis
Intervention: Drug: HuMax-CD20
9 Recruiting Ofatumumab Dose-Finding in RRMS Patients
Condition: Relapsing Remitting Multiple Sclerosis
Intervention: Drug: ofatumumab/placebo
10 Recruiting Zalutumumab in Patients With Non-Curable Head and Neck Cancer
Conditions: Head and Neck Cancer;   Squamous Cell Cancer
Interventions: Drug: Zalutumumab;   Other: Best Supportive Care
11 Active, not recruiting HuMax-CD20 in Follicular Lymphoma (FL) Patients Refractory to Rituximab
Condition: Follicular Lymphoma
Intervention: Drug: Ofatumumab-HuMax-CD20
12 Not yet recruiting Ofatumumab Retreatment and Maintenance Treatment in CLL Patients
Condition: B-Cell Chronic Lymphocytic Leukemia
Intervention: Drug: Ofatumumab
13 Completed HuMax-EGFr in Head and Neck Cancer
Condition: Head and Neck Neoplasms
Intervention: Drug: HuMax-EGFr
14 Recruiting HuMax-CD20 in B-Cell Chronic Lymphocytic Leukemia (B-CLL) Patients Failing Fludarabine and Alemtuzumab
Condition: B-Cell Chronic Lymphocytic Leukemia
Intervention: Drug: ofatumumab
15 Terminated Zalutumumab in Combination With Chemo-Radiation in a Certain Type of Lung Cancer
Condition: Non Small Cell Lung Cancer
Interventions: Biological: Zalutumumab;   Drug: cisplatin, docetaxel, vinorelbine, radiation
16 Recruiting Investigating Clinical Efficacy of Ofatumumab in Adult RA Patients Who Had an Inadequate Response to MTX Therapy
Conditions: Arthritis, Rheumatoid;   Rheumatoid Arthritis
Interventions: Drug: Ofatumumab;   Drug: Placebo
17 Recruiting Zalutumumab in Combination With Radiotherapy in Head and Neck Cancer Patients Ineligible for Platinum Based Chemotherapy
Conditions: Head and Neck Cancer;   Squamous Cell Carcinoma
Intervention: Drug: zalutumumab
18 Active, not recruiting Ofatumumab With Fludarabine and Cyclophosphamide in B-CLL Patients
Condition: B-Cell Chronic Lymphocytic Leukemia
Intervention: Drug: Ofatumumab
19 Completed Clinical Trial of HuMax-CD4, a New Drug to Treat Early Stage T-Cell Lymphoma in the Skin.
Condition: Cutaneous T-Cell Lymphoma
Intervention: Drug: HuMax-CD4
20 Completed Study of HuMax-CD20, a New Drug to Treat Early Stage Non-Hodgkin´s Follicular Lymphoma
Condition: Lymphoma, Follicular
Intervention: Drug: HuMax-CD20

Previous Page Studies Shown (1-20) Next (21-26)
  RSS Feed for studies found by your search that were received in the last 14 days
  Download Options




U.S. National Library of Medicine,  Contact Help Desk
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services